4//SEC Filing
Kelly Jason R 4
Accession 0001127602-24-013566
CIK 0001830214other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 4:49 PM ET
Size
6.3 KB
Accession
0001127602-24-013566
Insider Transaction Report
Form 4
Kelly Jason R
DirectorCEO & Founder
Transactions
- Award
Stock Option
2024-04-25+5,000,000→ 5,000,000 totalExercise: $2.50Exp: 2034-04-25→ Class A Common Stock (5,000,000 underlying)
Footnotes (1)
- [F1]The options are subject both to time-based and performance-based vesting criteria (the "Founder Options"). The performance-based vesting is tied to the achievement of four specified stock price hurdles within a five-year period, with 10% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $5.00, 10% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $7.50, 20% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $10.00 and the remaining 60% of the Founder Options vesting based on the achievement of a 90-calendar-day average stock price of $12.50. If any of the performance-based criteria are achieved during the five-year performance period, the awards will vest on the five-year anniversary of the grant date, subject to the Reporting Person's continued employment with Ginkgo on such anniversary.
Documents
Issuer
Ginkgo Bioworks Holdings, Inc.
CIK 0001830214
Entity typeother
Related Parties
1- filerCIK 0001845677
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 4:49 PM ET
- Size
- 6.3 KB